Stockscreener 앱 받기
38.68
0.21%
-0.0618
Astrana Health Inc 주식(ASTH)의 최신 뉴스
Astrana Health (ASTH) Shares Just Moved, So What Is Going On? - Sahm
Astrana Health Director David Schmidt Executes Option Exercise and Sells Shares via Issuer Repurchase - Kalkine Media
Astrana Health (NASDAQ: ASTH) director sells 20K shares back to company - Stock Titan
ASTH | Astrana Health Inc. Common FinancialsRevenue Breakdown - Quiver Quantitative
Astrana Health (NASDAQ:ASTH) Rating Lowered to Hold at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Surges 7.99% to $40.81 — Key Levels to WatchHigh Beta Stocks - Vinanet
5 Must-Read Analyst Questions From Astrana Health’s Q2 Earnings Call - Yahoo Finance
Astrana Health Inc (ASTH) Shares Surge 8.2% -- What GF Score of 85 Tells Investors - GuruFocus
Astrana Health (NASDAQ:ASTH) Rally Puts Growth In Focus - Kalkine Media
Astrana Health Jumps 7.1% After Truist Securities Maintains Buy - AlphaStreet
Astrana Health (ASTH) Surges 7.57% as Healthcare Services Stock Breaks HigherLow Risk Entry Stocks - Vinanet
Astrana Health (NASDAQ:ASTH) Shares Up 7.9%Still a Buy? - MarketBeat
Astrana Health (ASTH) Is Up 10.7% After Raising 2026 Guidance And Doubling Q2 Net IncomeHas The Bull Case Changed? - simplywall.st
ASTH Q2 2026 Earnings: 16.7% EPS Beat Drives OptimismSaaS Earnings Trends - Vinanet
Astrana Health: 81% Full-Risk And Profitable (NASDAQ:ASTH) - Seeking Alpha
Is Astrana Health Inc (ASTH) a Bargain After 8.1% Drop? GF Value Says Undervalued - GuruFocus
Astrana Health (NASDAQ:ASTH) Stock Price Down 5.7%What's Next? - MarketBeat
ASTRANA HEALTH, INC. : TRUIST SECURITIES RAISES TARGET PRICE TO $55 FROM $47 - Bitget
EVOLENT HEALTH, INC. : CITIGROUP RAISES TO BUY FROM NEUTRAL; CUTS TARGET PRICE TO $6 FROM $6.75 - Bitget
Truist Securities Adjusts Price Target on Astrana Health to $55 From $47, Keeps Buy Rating - marketscreener.com
Astrana Health Inc. (ASTH) Stock Analysis: Exploring A 34.77% Potential Upside - DirectorsTalk Interviews
Astrana Health Submits Q2 2026 SEC Form 10-Q Detailing Financials and Share Information - Kalkine Media
Astrana Health, Inc. Q2 2026: Revenue $972.5M, EPS $0.4— 10-Q Summary - TradingView
Astrana Health (ASTH) grows Q2 2026 revenue to $972.5M with stronger profit - stocktitan.net
Results: Astrana Health, Inc. Beat Earnings Expectations And Analysts Now Have New Forecasts - 富途牛牛
Employment Law Attorneys, at Blumenthal Nordrehaug Bhowmik De Blouw LLP, Filed a Lawsuit Against Astrana Health Management, Inc., for Alleged Violations of Meal & Rest Period Requirements - PR Newswire
Sei Investments Co. Raises Stake in Astrana Health, Inc. $ASTH - MarketBeat
Barclays Sticks to Their Buy Rating for Astrana Health (ASTH) - The Globe and Mail
Astrana Health (NASDAQ:ASTH) Raised to Buy at Wall Street Zen - MarketBeat
Astrana Health (ASTH) Stock Rises On Cash Flow Strength And Deleveraging - simplywall.st
Astrana Health Inc. Stock 12‑Month Price Target Raised to $50.5, Implies 48% Upside - TradingView
Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating - Moomoo
A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53 - Moomoo
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts By Investing.com - Investing.com Nigeria
Astrana Health (ASTH) Stock Sees Modest Fair Value Lift As Analysts Back Integration Progress - Yahoo Finance
Enterprise value to revenue forward of Astrana Health Inc. – FWB:3AM - TradingView
Astrana Health (ASTH) Surges 5.22% as Momentum Builds Toward Key ResistanceComposite Profile - Vinanet
ASTH Q2 Deep Dive: AI-Driven Operating Leverage and Strategic Expansion Shape Outlook - The Globe and Mail
Astrana Health beats EPS estimates, raises EBITDA guidance By Investing.com - Investing.com Nigeria
Astrana Health, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Astrana Health, Inc. 2026 Q2ResultsEarnings Call Presentation (NASDAQ:ASTH) 2026-08-06 - Seeking Alpha
Earnings call transcript: Astrana Health tops Q2 2026 profit forecasts - Investing.com
Astrana Health Q2 Earnings Call Highlights - MarketBeat
ASTH Looks 59.4% Undervalued on GF Value™ - GuruFocus
Astrana Health, Inc. (ASTH) Q2 Earnings Top Estimates - Yahoo Finance
ASTRANA HEALTH ($ASTH) Releases Q2 2026 Earnings - Quiver Quantitative
Earnings Flash (ASTH) Astrana Health, Inc. Posts Q2 Adjusted EPS $0.80 per Share, vs. FactSet Est of $0.79 - marketscreener.com
Earnings Flash (ASTH) Astrana Health, Inc. Reports Q2 Revenue $972.5M, vs. FactSet Est of $985.6M - marketscreener.com
(ASTH) Astrana Health, Inc. Expects Q3 Revenue Range $1.00B$1.03B - marketscreener.com
Astrana Health (NASDAQ:ASTH) Beats Q2 CY2026 Non-GAAP EPS Estimates, Stock Soars 5.1% - Barchart.com
Astrana Health, Inc. Reports Second Quarter 2026 Results - PR Newswire
Astrana Health earnings on deck after Q1 blowout results By Investing.com - Investing.com Canada
Astrana Health Seeks Acquisitions - marketscreener.com
Astrana Health Inc. (ASTH) Stock Forecasts - Yahoo Finance
Astrana Health Inc. Stock 12‑Month Price Target Raised to $48.75, Implies 37% Upside - TradingView
Dimensional Fund Advisors LP Boosts Stake in Astrana Health, Inc. $ASTH - MarketBeat
Astrana Health (ASTH) Q2 Earnings: What To Expect - Barchart.com
Astrana Health Inc. (ASTH) Stock Analysis: Poised For Growth With 37% Upside Potential - DirectorsTalk Interviews
A Look at Astrana Health Inc (ASTH) After 3.0% Decline -- GF Val - GuruFocus
Vanguard Portfolio Management (ASTH) discloses 2.65M-share stake in Astrana Health - Stock Titan
Astrana Health Inc. (ASTH) Slips 2.42% as Stock Tests Key Support LevelsNAAIM Exposure - Vinanet
0.20%
0.20%
자본화:
|
볼륨(24시간):